2022 Tutorial on Neoplastic Hematopathology: Extranodal and Nodal Marginal Zone Lymphoma Case Presentation

The goal of this activity is to update physicians on the latest advances in neoplastic hematopathology to improve the diagnosis of harmful and even potentially deadly cancers that include Hodgkin lymphoma, non-Hodgkin lymphoma, plasma cell myeloma, acute and chronic leukemia, myeloproliferative neoplasms, myelodysplastic syndromes, histiocytic tumors, and related disorders. This activity will provide a forum to discuss recent advances in the classification of hematopoietic tumors, including clinical and morphologic features, as well as the application and interpretation of immunological and molecular techniques in the diagnosis and classification of these diseases.

Upon completion of this activity, participants will be able to:

• Identify how to evaluate and respond to diagnostic problems that arise in neoplastic hematopathology;
• State how to utilize recent advances in the classification of hematopoietic tumors;
• Discuss how to interpret and apply immunologic and molecular genetic findings in the diagnosis of neoplastic hematologic disease;
• Describe how to implement the most recent classification of hematologic neoplasms;
• Recall new discoveries that might impact future classifications of hematologic neoplasms;
• Analyze the prognostic and therapeutic significance of new molecular genetic markers of these tumors.